Genzyme Biosurgery is committed to improving the way of life for orthopedic patients. As established leaders in orthopedic research, Genzyme consistently introduces new technologies and new ways to regrow damaged tissue. One such technology is Carticel, a breakthrough treatment to repair articular cartilage defects in the knee. Carticel provides orthopedic surgeons new options for treating patients with cartilage damage who have not responded adequately to surgical repair.
Founded in 1981, Genzyme is one of the largest and most established biotechnology companies in the world. They have more than 25 major products marketed in over 60 countries. Dedicated to research and development of advanced biotechnology capabilities Genzyme strives to address unmet medical needs.
Genzyme's focused effort to save and enhance the lives of patients with debilitating diseases has led to establishing breakthrough treatments that bring new hope to the medical field. Some of Genzyme's most effective products include treatments for heart disease, genetic diseases, orthopedic diseases, and cancer complications.
To learn more about Genzyme and their pioneering medical technology visit Genzyme.com.